Duopharma Biotech Bhd 2024 Integrated Report
Company: Duopharma Biotech Bhd
Sector: Manufacturing
Country: Malaysia
Year: 2024
Type: Integrated Report
Pages: 248
The report describes Duopharma Biotech's 2024 progress in sustainability governance, including Board and committee oversight of ESG matters. It reports completion of a Scope 3 baseline for six categories, solar installation across manufacturing sites, and a 5-Year Energy Efficiency Plan supporting the net-zero transition. The company also reports 36% women Directors on the Board, zero work-related fatalities and zero confirmed corruption cases. Sustainability performance data covers energy, water, waste and emissions, with prior-year comparatives marked as restated.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.